Allen & Overy and Harneys acted for Vivere Lifesciences Acquisition Corp. On 21 February, 2022, Vivere Lifesciences Acquisition Corporation submitted its listing application for the Main Board of the Hong...
Vivere Lifesciences Acquisition Corp.’s HK Listing
China’s US$4 Billion Rule 144A/Reg S Sovereign Bond Offering
Linklaters advised the Ministry of Finance of the People’s Republic of China on the matter. Allen & Overy has advised the joint lead managers and joint...